Read More 1 minute read Analyst Ratings News Price Target Reiteration Telsey Advisory Group Reiterates Market Perform on Ross Stores, Maintains $120 Price Target By Benzinga Newsdesk Today, 11:39 PM Telsey Advisory Group analyst Dana Telsey reiterates Ross Stores (NASDAQ:ROST) with a Market Perform and maintains $120 price target. ROST
Read More 1 minute read Analyst Ratings News Price Target Reiteration Barrington Research Reiterates Outperform on Avantax, Raises Price Target to $35 By Benzinga Newsdesk Today, 11:39 PM Barrington Research analyst Alexander Paris reiterates Avantax (NASDAQ:AVTA) with a Outperform and raises the price target from $30 to $35. AVTA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Jefferies Reiterates Buy on Star Bulk Carriers, Maintains $26 Price Target By Benzinga Newsdesk Today, 11:39 PM Jefferies analyst Omar Nokta reiterates Star Bulk Carriers (NASDAQ:SBLK) with a Buy and maintains $26 price target. SBLK
Read More 1 minute read Analyst Ratings News Price Target Reiteration Stephens & Co. Reiterates Overweight on Chuy’s Holdings, Maintains $33 Price Target By Benzinga Newsdesk Today, 11:39 PM Stephens & Co. analyst Joshua Long reiterates Chuy's Holdings (NASDAQ:CHUY) with a Overweight and maintains $33 price target. CHUY
Read More 1 minute read Analyst Ratings News Price Target Reiteration Canaccord Genuity Reiterates Buy on Repay Hldgs, Maintains $20 Price Target By Benzinga Newsdesk Today, 11:39 PM Canaccord Genuity analyst Joseph Vafi reiterates Repay Hldgs (NASDAQ:RPAY) with a Buy and maintains $20 price target. RPAY
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Inozyme Pharma, Maintains $23 Price Target By Benzinga Newsdesk Today, 11:39 PM Needham analyst Joseph Stringer reiterates Inozyme Pharma (NASDAQ:INZY) with a Buy and maintains $23 price target. INZY
Read More 1 minute read Analyst Color Analyst Ratings Biotech Earnings Beats General Guidance Health Care Large Cap Movers News Reiteration Trading Ideas Analyst Views West Pharmaceutical’s Q4 Earnings Impressive Despite Headwinds By Vandana Singh Today, 11:39 PM West Pharmaceutical Services Inc (NYSE:WST) reported Q4 2022 net sales of $708.7 million, down 3%, and organic net sales growth… WST
Read More 2 minute read Analyst Color Analyst Ratings News Price Target Reiteration Small Cap Tech Fastly Likely Gaining Share From Radware, Akamai, Cloudflare Under New Leadership, Analysts Say Post Q4 Beat By Anusuya Lahiri Today, 11:39 PM RBC Capital analyst Rishi Jaluria maintained Fastly Inc (NYSE:FSLY) with an Underperform and raised the price target from $6 to $9. Fastly… AKAM
Read More 1 minute read Analyst Ratings News Price Target Reiteration Tech Analysts Cheer Pegasystems Q4 Performance Amid Challenging Macro, Guidance Calls For Material Profitability In CY23 By Anusuya Lahiri Today, 11:39 PM RBC Capital analyst Rishi Jaluria maintained Pegasystems Inc (NASDAQ:PEGA) with an Outperform and raised the price target from $42 to $55. The… PEGA
Read More 4 minute read Analyst Color Analyst Ratings News Price Target Reiteration Top Stories Trading Ideas Roku Gets Apple iOS Comparison, Price Target Raises From Analysts After Q4 Beat By Chris Katje Today, 11:39 PM Connected television and streaming platform company Roku Inc (NASDAQ: ROKU) beat revenue and earnings per share estimates in the fourth quar AAPL